title: Generalized pustulosis and severe tubulointerstitial nephropathy as manifestations of carbamazepine hypersensitivity syndrome.
authors.forename: David
authors.initials: D
authors.lastname: Moreno-Ramírez
authors.forename: Begona
authors.initials: B
authors.lastname: García-Bravo
authors.forename: Antonio
authors.initials: A
authors.lastname: Rodríguez-Pichardo
authors.forename: Clotilde Ríos
authors.initials: CR
authors.lastname: Camacho
authors.forename: Francisco Camacho
authors.initials: FC
authors.lastname: Martínez
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003875:Drug Eruptions / Q000150:complications / Q000175:diagnosis / Q000209:etiology*; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009395:Nephritis, Interstitial / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D006435:Renal Dialysis; D018570:Risk Assessment; D012720:Severity of Illness Index; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine